FDA Adverse Event Malfunction Summary report: N

STELLANT

MDR report key: 2992141 · Received February 28, 2013

Report

Report Number
2992141
Event Type
Malfunction
Date Received
February 28, 2013
Date of Event
February 22, 2013
Report Date
February 28, 2013
Manufacturer
MEDRAD, INC
Product Code
DXT
Product Problem
Yes
Report Source
User Facility report
Reporter Location
IL, US
Reporter Occupation
NURSE

Narratives

Description of Event or Problem · 1

UPON OPENING DEVICE, IT WAS NOTED THAT THE END OF THE "CURLY" CONNECTION TUBING WAS NOT CONNECTED TO THE END CAP (PATIENT CONNECTION END) IN THE CT INJECTOR KIT. IT LOOKS AS IF PART OF THE SMALL TUBING IS STUCK IN THE END PIECE, BUT THE TUBING IS SUPPOSED TO BE CONNECTED AND WAS NOT.THE CT DEPARTMENT STATES THEY FOUND TWO PACKAGES IN TOTAL LIKE THIS RECENTLY AND HAVE SEEN THIS HAPPEN BEFORE ABOUT 2-3 TIMES. NO PATIENT WAS INVOLVED/HARMED. DEFECTIVE TUBING NOTED UPON PACKAGE OPENING.======================MANUFACTURER RESPONSE FOR MEDRAD STERILE DISPOSABLE SYRINGE WITH 60" T-CONNECTOR AND PRIME TUBE, STELLANT (PER SITE REPORTER).======================SPOKE WITH THE MANUFACTURER'S COMPLIANCE STAFF. THEY STATED THAT I SHOULD WAIT ABOUT 5 BUSINESS DAYS SO MEDRAD COULD REVIEW COMPLAINT TO SEE IF THEY WOULD LIKE TO RECEIVE THE PRODUCT FOR INVESTIGATION. THEY ARE PLANNING TO SEND REPLACEMENT BOX.WHAT WAS THE ORIGINAL INTENDED PROCEDURE?CT CONTRAST INJECTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
86878 STELLANT INJECTOR AND SYRINGE, ANGIOGRAPHIC DXT MEDRAD, INC * 139599

Patients

Seq Age Sex Outcome Treatment
1 *